Total Payments
$5,183
2024 Payments
$115.45
Companies
25
Transactions
116
Medicare Patients
4,915
Medicare Billing
$832,288
Payment Breakdown by Category
Food & Beverage$3,666 (70.7%)
Travel$1,467 (28.3%)
Education$50.00 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,666 | 113 | 70.7% |
| Travel and Lodging | $1,467 | 2 | 28.3% |
| Education | $50.00 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,934 | 22 | $0 (2022) |
| Edwards Lifesciences Corporation | $898.86 | 12 | $0 (2023) |
| Abbott Laboratories | $549.08 | 12 | $0 (2020) |
| Medtronic Vascular, Inc. | $309.16 | 11 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $242.49 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $238.36 | 10 | $0 (2024) |
| Amgen Inc. | $181.63 | 10 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $164.76 | 4 | $0 (2019) |
| ABIOMED | $125.19 | 1 | $0 (2022) |
| Medtronic, Inc. | $114.79 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.45 | 4 | Novartis Pharmaceuticals Corporation ($57.14) |
| 2023 | $230.80 | 7 | Medtronic, Inc. ($114.79) |
| 2022 | $365.38 | 8 | Edwards Lifesciences Corporation ($130.21) |
| 2021 | $242.25 | 8 | E.R. Squibb & Sons, L.L.C. ($129.21) |
| 2020 | $477.85 | 9 | Edwards Lifesciences Corporation ($231.98) |
| 2019 | $686.85 | 20 | Boston Scientific Corporation ($172.29) |
| 2018 | $1,968 | 28 | Boston Scientific Corporation ($1,659) |
| 2017 | $1,097 | 32 | Edwards Lifesciences Corporation ($326.76) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $41.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: Cardiovascular | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardiology | ||||||
| 06/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Cardiology | ||||||
| 05/16/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $20.69 | General |
| 02/25/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $99.91 | General |
| Category: Transcatheter Valve Systems | ||||||
| 02/21/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Cardiology | ||||||
| 02/21/2023 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Stents | ||||||
| 02/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/10/2022 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $103.18 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/01/2022 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/27/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: Cardiovascular | ||||||
| 09/20/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Cardiology | ||||||
| 07/12/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/20/2022 | Boston Scientific Corporation | General - Vascular Intervention (Device) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 04/26/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: DIABETES | ||||||
| 04/19/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $125.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2021 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/11/2021 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $3.05 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/16/2021 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/21/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Cardiology | ||||||
| 06/17/2021 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/10/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 975 | 1,195 | $2.3M | $144,987 |
| 2022 | 20 | 1,252 | 1,667 | $3.2M | $226,701 |
| 2021 | 23 | 1,311 | 1,735 | $3.1M | $235,362 |
| 2020 | 22 | 1,377 | 2,010 | $3.1M | $225,238 |
Total Patients
4,915
Total Services
6,607
Medicare Billing
$832,288
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 274 | $161,934 | $31,907 | 19.7% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 29 | 29 | $302,934 | $21,717 | 7.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 33 | 40 | $198,880 | $21,087 | 10.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 51 | 51 | $440,742 | $13,786 | 3.1% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 56 | 56 | $403,592 | $10,141 | 2.5% |
| 92941 | Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | Facility | 2023 | 14 | 14 | $78,064 | $9,206 | 11.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $52,838 | $8,489 | 16.1% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 22 | 22 | $227,348 | $8,066 | 3.5% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 13 | 13 | $124,085 | $3,849 | 3.1% |
| 93455 | Insertion of tube in bypass graft for diagnosis with review by radiologist | Facility | 2023 | 15 | 16 | $134,208 | $3,494 | 2.6% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 46 | 46 | $59,018 | $3,359 | 5.7% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 25 | 25 | $19,775 | $2,383 | 12.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 161 | 167 | $63,126 | $2,161 | 3.4% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 11 | 144 | $13,680 | $1,500 | 11.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 153 | 171 | $13,338 | $1,397 | 10.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $6,030 | $1,053 | 17.5% |
| 93572 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | Facility | 2023 | 14 | 17 | $10,081 | $898.11 | 8.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 37 | $6,364 | $493.85 | 7.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 84 | 111 | $540,225 | $58,721 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 271 | 338 | $197,757 | $42,131 | 21.3% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2022 | 41 | 41 | $423,306 | $32,515 | 7.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 77 | 77 | $657,194 | $22,378 | 3.4% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 86 | 87 | $615,657 | $15,693 | 2.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 89 | 89 | $79,979 | $14,125 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 100 | $39,060 | $7,442 | 19.1% |
About Dr. Thomas Kramer, M.D
Dr. Thomas Kramer, M.D is a Interventional Cardiology healthcare provider based in Anchorage, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083635742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Kramer, M.D has received a total of $5,183 in payments from pharmaceutical and medical device companies, with $115.45 received in 2024. These payments were reported across 116 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,666).
As a Medicare-enrolled provider, Kramer has provided services to 4,915 Medicare beneficiaries, totaling 6,607 services with total Medicare billing of $832,288. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Anchorage, AK
- Active Since 07/21/2006
- Last Updated 01/14/2026
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1083635742
Products in Payments
- CROSSBOSS (Device) $1,482
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $433.94
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $256.39
- ELIQUIS (Drug) $221.76
- ENTRESTO (Drug) $160.69
- Absorb GT1 (Device) $137.15
- CoreValve Evolut (Device) $128.12
- Impella (Device) $125.19
- Xience Sierra Coronary Stent (Device) $119.87
- Xience Sierra Coronary Stent System (Device) $111.66
- GENERAL VASCULAR ACCESS (Device) $108.87
- Repatha (Biological) $107.46
- HeartWare HVAD (Device) $105.77
- Edwards SAPIEN XT Transcatheter Heart Valve (Device) $100.85
- COREVALVE EVOLUT R (Device) $99.91
- SYNERGY (Device) $85.00
- LEQVIO (Drug) $81.80
- Resolute (Device) $75.27
- Corlanor (Drug) $74.17
- KENGREAL (Drug) $72.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.